MISSION, Kan., April 30, 2018 -- (Family Features) Alzheimer’s disease is the sixth leading cause of death overall in the United States and affects more than 5 million Americans. According to experts, this number could triple to nearly 16 million people by 2050. A momentous scientific study focused on early detection of Alzheimer’s disease, and tracking it over time, seeks healthy volunteers without memory problems, as well as people who have mild memory problems and those who have been diagnosed with mild dementia due to Alzheimer’s disease.
|
|||||
The prestigious Alzheimer’s Disease Neuroimaging Initiative – or ADNI – funded by the National Institutes of Health, is one of the largest and longest running Alzheimer’s disease trials in history. Now in the third phase of trials, researchers are studying how quickly things like reasoning and the ability to perform certain functions change in the aging brain. Researchers need to better understand the disease progression in order to speed the pace of discovery in the race to prevent, treat and cure Alzheimer’s disease.
“It is extremely important that more people get involved in the fight against Alzheimer’s disease, which affects nearly all of us in some way,” said Michael Weiner, MD, principal investigator of the study. “We need to know how Alzheimer’s disease progresses in order to discover new treatments that could significantly improve the way we treat it in the future.”
The study uses state-of-the-art imaging to monitor brain levels of two proteins called tau and amyloid, both of which are significant indicators of Alzheimer’s disease. Researchers track cognitive function through computer tests at home and in a doctor’s office, which includes measuring changes in one’s ability to handle money, a common warning sign of the disease.
“One of the biggest challenges researchers face is finding people to volunteer to take part in studies,” said Weiner. “We can beat Alzheimer’s, but we can’t do it without volunteers. We need help.”
The ADNI Study needs 800 people to enroll in sites across the United States and in Canada. Researchers are looking for people between the ages of 55 and 90 who have normal thinking and memory function, as well as those who have mild memory problems and those who have been diagnosed with mild dementia due to Alzheimer’s disease. No medication is involved.
Potential study volunteers can learn more by visiting www.ADNI3.org or by calling 1-888-2-ADNI-95 (1-888-223-6495).
Michael French
[email protected]
1-888-824-3337
editors.familyfeatures.com
About Family Features Editorial Syndicate
Established in 1974, Family Features is a leading provider of free food and lifestyle content for print and online publications. Our articles, photos, videos and web content solutions save you time, money and help create advertising opportunities. Registration is fast and free – with absolutely no obligation. Visit editors.familyfeatures.com for more information.
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/9fbc4729-166c-4135-90f2-796899ff0219


Amazon to Expand Drone Delivery to 500 U.S. Locations
Ampol Profit Surges as Refining Margins Hit Record Highs
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p
SK Hynix Shares Fall as Workers Reject Wage Deal
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
Nvidia Eyes Perplexity Investment at $30 Billion Valuation
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments
California Seeks Paramount Divestitures in Warner Bros. Merger
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 



